102 related articles for article (PubMed ID: 29091013)
1. Cost of illness of metastatic prostate cancer: a perspective of costs for new treatment options in The Netherlands.
Ter Heine R; Frederix GW; Geenen JW; Hövels AM; van Vulpen M; Kooistra A; De Klerk JM; Bloemendal HJ
J Comp Eff Res; 2017 Oct; 6(7):575-581. PubMed ID: 29091013
[TBL] [Abstract][Full Text] [Related]
2. Costs of prostate cancer, metastatic to the bone, in the Netherlands.
Groot MT; Boeken Kruger CG; Pelger RC; Uyl-de Groot CA
Eur Urol; 2003 Mar; 43(3):226-32. PubMed ID: 12600424
[TBL] [Abstract][Full Text] [Related]
3. Economic Evaluation of Treating Skeletal-Related Events among Prostate Cancer Patients.
Zhong Y; Valderrama A; Yao J; Donga P; Bilir P; Neumann PJ
Value Health; 2018 Mar; 21(3):304-309. PubMed ID: 29566837
[TBL] [Abstract][Full Text] [Related]
4. The economic burden of skeletal-related events among elderly men with metastatic prostate cancer.
Jayasekera J; Onukwugha E; Bikov K; Mullins CD; Seal B; Hussain A
Pharmacoeconomics; 2014 Feb; 32(2):173-91. PubMed ID: 24435407
[TBL] [Abstract][Full Text] [Related]
5. Adenocarcinoma of the prostate: an expensive way to die.
Piper NY; Kusada L; Lance R; Foley J; Moul J; Seay T
Prostate Cancer Prostatic Dis; 2002; 5(2):164-6. PubMed ID: 12497008
[TBL] [Abstract][Full Text] [Related]
6. [The perioperative charge equivalence of radical prostatectomy with 1-year follow up since the diagnosis of prostate cancer].
Namiki S; Ito A; Ishidoya S; Satoh M; Saito S; Arai Y; Tochigi T; Kuwahara M; Ioritani N; Koinuma N
Hinyokika Kiyo; 2004 Feb; 50(2):71-5. PubMed ID: 15101159
[TBL] [Abstract][Full Text] [Related]
7. Impact of skeletal complications on total medical care costs among patients with bone metastases of lung cancer.
Delea TE; McKiernan J; Brandman J; Edelsberg J; Sung J; Raut M; Oster G
J Thorac Oncol; 2006 Jul; 1(6):571-6. PubMed ID: 17409919
[TBL] [Abstract][Full Text] [Related]
8. The cost of treating skeletal-related events in patients with prostate cancer.
Lage MJ; Barber BL; Harrison DJ; Jun S
Am J Manag Care; 2008 May; 14(5):317-22. PubMed ID: 18471035
[TBL] [Abstract][Full Text] [Related]
9. Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice.
Delea T; McKiernan J; Brandman J; Edelsberg J; Sung J; Raut M; Oster G
J Support Oncol; 2006; 4(7):341-7. PubMed ID: 16892696
[TBL] [Abstract][Full Text] [Related]
10. Hospital resource utilization and treatment cost of skeletal-related events in patients with metastatic breast or prostate cancer: estimation for the Portuguese National Health System.
Félix J; Andreozzi V; Soares M; Borrego P; Gervásio H; Moreira A; Costa L; Marcelo F; Peralta F; Furtado I; Pina F; Albuquerque C; Santos A; Passos-Coelho JL;
Value Health; 2011 Jun; 14(4):499-505. PubMed ID: 21669375
[TBL] [Abstract][Full Text] [Related]
11. Healthcare utilization and costs associated with skeletal-related events in prostate cancer patients with bone metastases.
Hagiwara M; Delea TE; Saville MW; Chung K
Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):23-7. PubMed ID: 23146970
[TBL] [Abstract][Full Text] [Related]
12. TRAPEZE: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of chemotherapy with zoledronic acid, strontium-89, or both, in men with bony metastatic castration-refractory prostate cancer.
James N; Pirrie S; Pope A; Barton D; Andronis L; Goranitis I; Collins S; McLaren D; O'Sullivan J; Parker C; Porfiri E; Staffurth J; Stanley A; Wylie J; Beesley S; Birtle A; Brown J; Chakraborti P; Russell M; Billingham L
Health Technol Assess; 2016 Jul; 20(53):1-288. PubMed ID: 27434595
[TBL] [Abstract][Full Text] [Related]
13. The Clinical and Economic Impacts of Skeletal-Related Events Among Medicare Enrollees With Prostate Cancer Metastatic to Bone.
McDougall JA; Bansal A; Goulart BH; McCune JS; Karnopp A; Fedorenko C; Greenlee S; Valderrama A; Sullivan SD; Ramsey SD
Oncologist; 2016 Mar; 21(3):320-6. PubMed ID: 26865591
[TBL] [Abstract][Full Text] [Related]
14. Utilizing time-driven activity-based costing to understand the short- and long-term costs of treating localized, low-risk prostate cancer.
Laviana AA; Ilg AM; Veruttipong D; Tan HJ; Burke MA; Niedzwiecki DR; Kupelian PA; King CR; Steinberg ML; Kundavaram CR; Kamrava M; Kaplan AL; Moriarity AK; Hsu W; Margolis DJ; Hu JC; Saigal CS
Cancer; 2016 Feb; 122(3):447-55. PubMed ID: 26524087
[TBL] [Abstract][Full Text] [Related]
15. Changing costs of metastatic non small cell lung cancer in the Netherlands.
Keusters WR; de Weger VA; Hövels A; Schellens JHM; Frederix GWJ
Lung Cancer; 2017 Dec; 114():56-61. PubMed ID: 29173766
[TBL] [Abstract][Full Text] [Related]
16. Clinical and economic burden of bone metastasis and skeletal-related events in prostate cancer.
Yong C; Onukwugha E; Mullins CD
Curr Opin Oncol; 2014 May; 26(3):274-83. PubMed ID: 24626126
[TBL] [Abstract][Full Text] [Related]
17. The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer.
Delea T; Langer C; McKiernan J; Liss M; Edelsberg J; Brandman J; Sung J; Raut M; Oster G
Oncology; 2004; 67(5-6):390-6. PubMed ID: 15713995
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of androgen suppression therapies in advanced prostate cancer.
Bayoumi AM; Brown AD; Garber AM
J Natl Cancer Inst; 2000 Nov; 92(21):1731-9. PubMed ID: 11058616
[TBL] [Abstract][Full Text] [Related]
19. The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain.
Pockett RD; Castellano D; McEwan P; Oglesby A; Barber BL; Chung K
Eur J Cancer Care (Engl); 2010 Nov; 19(6):755-60. PubMed ID: 19708928
[TBL] [Abstract][Full Text] [Related]
20. Comparing hospital-based resource utilization and costs for prostate cancer patients with and without bone metastases.
Seal B; Sullivan SD; Ramsey SD; Asche CV; Shermock K; Sarma S; Zagadailov EA; Farrelly E; Eaddy M
Appl Health Econ Health Policy; 2014 Oct; 12(5):547-57. PubMed ID: 25005491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
